1.6 Million Britons on Weight Loss Jabs
New research shows 1.6 million UK adults used weight loss injections last year, with many using drugs 'off-label'. Experts warn of safety risks and access inequality. Read the full report.
Category : Search result: Rybelsus
Novo Nordisk Alzheimer's trial fails, shares drop
Novo Nordisk's Rybelsus fails to slow Alzheimer's cognitive decline in major trial, causing a 10% share price drop. Read the full analysis of this pharmaceutical setback.
Page 1 of 1